Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02192827 · ClinicalTrials.gov registry record · Phase 3
Use of Dexamethasone in Pediatric Asthma Exacerbations
A Phase 3 study, sponsored by University at Buffalo.
- Completed
- Registry status
- Phase 3
- Development phase
- 318
- Enrollment target
NCT02192827: Completed Phase 3 study, sponsored by University at Buffalo.
NCT02192827 is a Phase 3 study that has completed, run by University at Buffalo. The registered enrollment target is 318 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02192827, a Phase 3 study, has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 318 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the efficacy of a single dose of dexamethasone vs. two doses of dexamethasone in mild and moderate asthma exacerbations pediatric patients.
Primary Outcome
The investigators will determine if each patient had any unscheduled visits to the emergency room, urgent care or primary care physician.
Interventions
- DRUG Dexamethasone Sodium Phosphate Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2015-04 |
| Est. Completion | 2018-03 |
| Phase | Phase 3 |
What the finished NCT02192827 record still lists
NCT02192827 is an interventional study that assigns participants to a tested intervention. The registered 318 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 1 intervention - of which Dexamethasone Sodium Phosphate Injection is the first listed.
NCT02192827 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02192827 about?
NCT02192827 is a clinical study titled "Use of Dexamethasone in Pediatric Asthma Exacerbations". The purpose of this study is to compare the efficacy of a single dose of dexamethasone vs. two doses of dexamethasone in mild and moderate asthma exacerbations pediatric patients.
What is the current status of trial NCT02192827?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 318 participants. The study started on 2015-04. Estimated completion is 2018-03.
What interventions are being tested in trial NCT02192827?
The interventions under investigation include: Dexamethasone Sodium Phosphate Injection (DRUG).
Who is sponsoring clinical trial NCT02192827?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02192827's enrollment target sits among peer trials
318 1087th of 2000 higher than 912 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05488340 · 318 participants · Phase 2
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
- NCT05675735 · 318 participants · NA
Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder
- NCT05895786 · 318 participants · Phase 3
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- NCT06051617 · 318 participants · Phase 3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia